News & analysis on the clinical development and manufacture of large molecule drugs
By Natalie Morrison
- Last updated on
Former Roche pharmaceutical division CEO Burns also serves on the boards of Roche, Genentech, Chugai, Masters Pharmaceuticals, Biotie Therapies and Shire.
Also new to the board is Jean-Paul Prieels, who was once head of research at GSK Vaccines, is also a board member for Immune Health and Pevion.
Riccardo Cortese, CEO and co-founder of Okairos said: "Both Bill Burns and Jean-Paul Prieels have led major pharmaceutical divisions and understand how to take great science through clinical trials to ultimately benefit patients."